The National Institutes of Health (NIH) issued a request for information (RFI) to gather public input on the NIH-Wide Strategic Plan for COVID-19 Research. The agency notes that this will be a “living document,” which will be continually updated to reflect new challenges presented by COVID-19.
The strategic plan can be found here and outlines the following five priorities and three crosscutting strategies:
- Five Priorities:
- Improve fundamental knowledge of SARS-CoV-2 and COVID-19;
- Advance detection and diagnosis of COVID-19;
- Advance treatment of COVID-19;
- Improve prevention of SARS-CoV-2 infection; and
- Prevent and redress poor COVID-19 outcomes in health disparity and vulnerable populations.
- Three Crosscutting Strategies:
- Partnering to promote collaborative science;
- Supporting research workforce infrastructure; and
- Investing in data science.
The NIH invites stakeholders throughout the scientific research, advocacy, and clinical practice communities, as well as the general public to comment on the strategic plan. Specifically, the agency seeks comments on any or all of the following topics:
- Significant research gaps or barriers not identified in the existing framework above;
- Resources required or lacking or existing leverageable resources that could advance the priorities;
- Emerging scientific advances or techniques in basic, diagnostic, therapeutic, or vaccine research that may accelerate the research priorities detailed in the framework above; and
- Additional ideas for bold, innovative research initiatives, processes, or data-driven approaches that could advanced the response to COVID-19.
Comments can be made here and are due December 7.